Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mild-moderate Cognitive Impairment”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT05858541
What this trial is testing

The Effects of Music Listening on Anxiety and Agitation in People With Mild and Moderate Cognitive Impairment

Who this might be right for
AnxietyAgitated Depression
University of Southern California 64
Post-approval studies (Phase 4)Looking for participantsNCT05924425
What this trial is testing

Daridorexant to Treat Insomnia in Patients With Mild Cognitive Impairment and Mild to Moderate Alzheimer Disease

Who this might be right for
Alzheimer DiseaseInsomnia DisorderSleep
University Hospital, Montpellier 62
Testing effectiveness (Phase 2)Study completedNCT04971733
What this trial is testing

Assess Safety and Target Engagement of E2814 in Participants With Mild to Moderate Cognitive Impairment Due to Dominantly Inherited Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Eisai Inc. 8
Not applicableEnrolling By InvitationNCT06245031
What this trial is testing

Extension to a Pivotal Study of Sensory Stimulation in Alzheimer's Disease (OLE Hope Study, CA-0015)

Who this might be right for
Alzheimer DiseaseCognitive ImpairmentMild Cognitive Impairment+5 more
Cognito Therapeutics, Inc. 402
Testing effectiveness (Phase 2)UnknownNCT03806478
What this trial is testing

Study of APH-1105 in Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
DementiaAlzheimer Disease 1Alzheimer Disease 2+1 more
Aphios 60
Not applicableLooking for participantsNCT06799429
What this trial is testing

Train Your Brain Fitness SC: An Exercise Intervention for People With Cognitive Impairments

Who this might be right for
Mild-moderate Cognitive Impairment
University of South Carolina 50
Early research (Phase 1)Ended earlyNCT02614131
What this trial is testing

LY2599666 in Healthy Participants and Participants With Mild Cognitive Impairment or Alzheimer's Disease (AD)

Who this might be right for
HealthyAlzheimer's DiseaseMild Cognitive Impairment
Eli Lilly and Company 50
Post-approval studies (Phase 4)Study completedNCT00035204
What this trial is testing

The Effects on Sleep, Attention, and Gastrointestinal Tolerance of Galantamine and Donepezil in Patients With Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 63
Early research (Phase 1)Study completedNCT01716637
What this trial is testing

Short Term Efficacy and Safety of Perispinal Administration of Etanercept in Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Life Extension Foundation Inc. 12
Not applicableStudy completedNCT04884529
What this trial is testing

Virtual Chair Yoga for Older Adults and Caregivers: Randomized Controlled Trial

Who this might be right for
DementiaMild Cognitive Impairment
Lady Davis Institute 30
Not applicableStudy completedNCT02660437
What this trial is testing

PCO2 Oscillations During Exercise: Relation to Cerebral Blood Flow and to Cognitive Dysfunction in COPD

Who this might be right for
Chronic Obstructive Pulmonary Disease
Schön Klinik Berchtesgadener Land 91
Not applicableEnrolling By InvitationNCT07733726
What this trial is testing

Oral Motor and Cognitive Dual-Task Training (OMCDT) Program for Improving Oral and Cognitive Functions Among People With Oral Frailty

Who this might be right for
Oral FrailtyMild Cognitive Impairment (MCI)Moderate Cognitive Impairment
The Hong Kong Polytechnic University 66
Testing effectiveness (Phase 2)Study completedNCT06745583
What this trial is testing

Assess the Safety of EI-1071 and the Effects of EI-1071 on Neuroinflammation in Alzheimer's Disease Patients

Who this might be right for
Mild, Moderate, or Severe Alzheimer's Disease
Elixiron Immunotherapeutics Inc. 7
Not applicableLooking for participantsNCT07764250
What this trial is testing

Comparative Evaluation of Immediate vs Progressive Standing Dual Task Training in Elderly With Mild and Moderate Cognitive Impairment

Who this might be right for
Cognitive ImpairmentCognitive Impairment, MildModerate Cognitive Impairment
Shifa Tameer-e-Millat University 96
Not applicableStudy completedNCT00611533
What this trial is testing

Placebo Controlled Study of Atomoxetine in the Treatment of Mild to Moderate Cognitive Difficulties in Menopausal Women

Who this might be right for
MenopauseCognitive Disturbances
University of Pennsylvania 16
Early research (Phase 1)Study completedNCT02624778
What this trial is testing

LY3002813 in Participants With Memory Damage Due to Alzheimer's Disease (AD) or AD

Who this might be right for
Alzheimer Disease
Eli Lilly and Company 61
Not applicableStudy completedNCT01937221
What this trial is testing

Novel Retinal Imaging Biomarkers in Early Alzheimer's Disease

Who this might be right for
Mild Cognitive ImpairmentMild to Moderate Cognitive Impairment
Duke University 60
Testing effectiveness (Phase 2)Looking for participantsNCT07058688
What this trial is testing

NTRX-07 in Participants With Alzheimer's Disease

Who this might be right for
Alzheimer DiseaseMild Cognitive Impairment
NeuroTherapia, Inc. 48
Not applicableLooking for participantsNCT07284446
What this trial is testing

Depressive Symptoms, Cognitive Impairment, and Outcomes in Hospitalized Chronic Heart Failure Patients

Who this might be right for
Congestive Heart Failure ChronicCognitive Impairment, MildDepressive Symptoms Mild to Moderate in Severity
Lithuanian University of Health Sciences 300
Large-scale testing (Phase 3)Looking for participantsNCT06976216
What this trial is testing

Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Bristol-Myers Squibb 586
Next Page